Inverse relationship between the expression of the human papillomavirus type 16 transcription factor E2 and virus DNA copy number during the progression of cervical intraepithelial neoplasia

Journal of General Virology

Volumn 81, Issue 7, 2000, Pages 1825-1832

  Stevenson, Mark ^a   Hudson, Lucy C ^a   Burns, Julie E ^a   Stewart, Roy L ^b   Wells, Michael ^b   Maitland, Norman J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ANTIBODY; TRANSCRIPTION FACTOR; VIRUS DNA;

ARTICLE; CANCER GRADING; CANCER INVASION; CARCINOMA CELL; CHROMOSOME MICRODISSECTION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ANIMALIA; DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0033918902     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-7-1825     Document Type: Article

References (29)

1. Bouvard, V., Storey, A., Pim, D. & Banks, L. (1994). Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes. EMBO Journal 13, 5451-5459.
2. Chiang, C.-M., Ustav, M., Stenlund, A., Ho, T. F., Broker, T. R. & Chow, L. T. (1992). Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proceedings of the National Academy of Sciences, USA 89, 5799-5803.
3. Chow, L. T. & Broker, T. R. (1994). Papillomavirus DNA replication. Intervirology 37, 150-158.
4. Del Vecchio, A. M., Romanczuk, H., Howley, P. M. & Baker, C. C. (1992). Transient replication of human papillomavirus DNAs. Journal of Virology 66, 5949-5958.
5. Desaintes, C., Goyat, S., Garbay, S., Yaniv, M. & Thierry, F. (1999). Papillomavirus E2 induces p53-independent apoptosis in HeLa cells. Oncogene 18, 4538-4545.
6. DiSaia, P. J. & Creasman, W. T. (1989). Preinvasive disease of the cervix, vagina and vulva. In Clinical Gynecologic Oncology, 3rd edn, pp. 58-125. St Louis, MO: C. V. Mosby.
7. Fowler, J. (1993). Screening for cervical cancer. Current terminology, classification, and technique. Postgraduate Medicine 93, 57-70.
8. Graham, D. A. & Herrington, C. S. (1998). The induction of chromosome abnormalities by human papillomaviruses. Papillomavirus Report 9, 1-5.
9. Ham, J., Dostatni, N., Gauthier, J.-M. & Yaniv, M. (1991). The papillomavirus E2 protein: a factor with many talents. Trends in Biochemical Sciences 16, 440-444.
10. Higgins, G. D., Uzelin, D. M., Phillips, G. E. & Burrell, C. J. (1991). Presence and distribution of human papillomavirus sense and antisense RNA transcripts in genital cancers. Journal of General Virology 72, 885-895.
11. Kalantari, M., Karlsen, F., Kristensen, G., Holm, R., Hagmar, B. & Johansson, B. (1998). Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. International Journal of Gynecological Pathology 17, 146-153.
12. Krajinovic, M., Lazic, J., Stanimirovic, B., Diklic, V. & Savic, A. (1993). The E2 region of HPV 16 in relation to different types of cervical lesions. Journal of Medical Virology 41, 1-5.
13. Lusky, M., Hurwitz, J. & Seo, Y.-S. (1994). The bovine papillomavirus E2 protein modulates the assembly of but is not stably maintained in a replication-competent multimeric E1-replication origin complex. Proceedings of the National Academy of Sciences, USA 91, 8895-8899.
14. Macintosh, C. A., Stower, M., Reid, N. & Maitland, N. J. (1998). Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Research 58, 23-28.
15. Maitland, N. J., Conway, S., Wilkinson, N. S., Ramsdale, J., Morris, J. R., Sanders, C. M., Burns, J. E., Stern, P. L. & Wells, M. (1998). Expression patterns of the human papillomavirus type 16 transcription factor E2 in low-and high-grade cervical intraepithelial neoplasia. Journal of Pathology 186, 275-280.
16. Matsukura, T., Koi, S. & Sugase, M. (1989). Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology 172, 63-72.
17. Resnick, M., Lester, S., Tate, J. E., Sheets, E. E., Sparks, C. & Crum, C. P. (1996). Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia. Human Pathology 27, 234-239.
18. Richart, R. M., Masood, S., Syrjänen, K. J., Vassilakos, P., Kaufman, R. H., Meisels, A., Olszewski, W. T., Sakamoto, A., Stoler, M. H., Vooijs, G. P. & Wilbur, D. C. (1998). Human papillomavirus. International Academy of Cytology - IAC Task Force summary. Diagnostic cytology towards the 21st century: an international expert conference and tutorial. Acta Cytologica 42, 50-58.
19. Rocha-Zavaleta, L., Jordan, D., Pepper, S., Corbitt, G., Clarke, F., Maitland, N. J., Sanders, C. M., Arrand, J. R., Stern, P. L. & Stacey, S. N. (1997). Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia. British Journal of Cancer 75, 1144-1150.
20. Sanders, C. M., Stern, P. L. & Maitland, N. J. (1995). Characterization of human papillomavirus type 16 E2 protein and subdomains expressed in insect cells. Virology 211, 418-433.
21. Schneider, A., Oltersdorf, T., Schneider, V. & Gissmann, L. (1987). Distribution pattern of human papilloma virus 16 genome in cervical neoplasia by molecular in situ hybridization of tissue sections. International Journal of Cancer 39, 717-721.
22. Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A. & zur Hausen, H. (1985). Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314, 111-114.
23. Sedman, J. & Stenlund, A. (1996). The initiator protein E1 binds to the bovine papillomavirus origin of replication as a trimeric ring-like structure. EMBO Journal 15, 5085-5092.
24. Singer, M. & Berg, P. (1991). SV40 early gene transcription. In Genes & Genomes, pp. 489-504. Edited by C. Dempster & S. S. Wright. Mill Valley, CA: University Science Books.
25. Stubenrauch, F., Colbert, A. M. E. & Laimins, L. A. (1998). Trans-activation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions. Journal of Virology 72, 8115-8123.
26. Webster, K., Parish, J., Pandya, M., Stern, P. L., Clarke, A. R. & Gaston, K. (2000). The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. Journal of Biological Chemistry 275, 87-94.
27. Yee, C., Krishnan-Hewlett, I., Baker, C. C., Schlegel, R. & Howley, P. M. (1985). Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. American Journal of Pathology 119, 361-366.
28. Ziol, M., Di Tomaso, C., Biaggi, A., Tepper, M., Piquet, P., Carbillon, L., Uzan, M. & Guettier, C. (1998). Virological and biological characteristics of cervical intraepithelial neoplasia grade I with marked koilocytotic atypia. Human Pathology 29, 1068-1073.
29. zur Hausen, H. (1994). Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Current Topics in Microbiology and Immunology 186, 131-156.